PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,748,000 | -28.5% | 459,930 | -4.2% | 0.00% | 0.0% |
| Q4 2019 | $2,444,000 | +8.5% | 480,181 | +7.8% | 0.00% | 0.0% |
| Q3 2019 | $2,252,000 | -29.7% | 445,573 | -14.2% | 0.00% | 0.0% |
| Q2 2019 | $3,202,000 | -5.6% | 519,029 | -29.0% | 0.00% | 0.0% |
| Q1 2019 | $3,391,000 | -5.8% | 730,754 | -14.7% | 0.00% | 0.0% |
| Q4 2018 | $3,598,000 | -50.2% | 856,749 | -25.6% | 0.00% | -50.0% |
| Q3 2018 | $7,223,000 | +57.3% | 1,151,967 | +101.7% | 0.00% | 0.0% |
| Q2 2018 | $4,591,000 | +108.8% | 571,001 | +93.7% | 0.00% | +100.0% |
| Q1 2018 | $2,199,000 | +94.9% | 294,719 | +55.4% | 0.00% | – |
| Q4 2017 | $1,128,000 | -10.7% | 189,618 | +10.5% | 0.00% | – |
| Q3 2017 | $1,263,000 | -73.3% | 171,591 | -75.4% | 0.00% | -100.0% |
| Q2 2017 | $4,739,000 | -64.7% | 697,865 | -51.0% | 0.00% | -75.0% |
| Q1 2017 | $13,443,000 | +293.3% | 1,424,014 | +259.9% | 0.00% | +300.0% |
| Q4 2016 | $3,418,000 | +710.0% | 395,626 | +295.4% | 0.00% | – |
| Q2 2016 | $422,000 | -67.4% | 100,059 | -66.3% | 0.00% | -100.0% |
| Q1 2016 | $1,294,000 | -37.4% | 296,896 | -11.9% | 0.00% | 0.0% |
| Q4 2015 | $2,067,000 | +8.4% | 337,096 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $1,906,000 | +38020.0% | 333,265 | +46838.7% | 0.00% | – |
| Q2 2015 | $5,000 | -95.9% | 710 | -97.6% | 0.00% | – |
| Q1 2014 | $122,000 | – | 29,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,583,925 | $8,007,000 | 1.48% |
| Phocas Financial Corp. | 1,022,708 | $5,169,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,776,490 | $8,980,000 | 0.32% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,350,000 | $37,154,000 | 0.28% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 716,880 | $3,624,000 | 0.23% |
| J. Goldman & Co LP | 499,698 | $2,526,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 1,257,098 | $6,355,000 | 0.15% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $19,957,000 | 0.14% |
| EAGLE ASSET MANAGEMENT INC | 4,504,094 | $22,768,000 | 0.12% |
| Worth Venture Partners, LLC | 32,956 | $167,000 | 0.10% |